Insider · CIK 0001483687

Deerfield Private Design Fund II, L.P.

CIK 0001483687 Name as filed on the most recent filing

Filed as Deerfield Private Design Fund II, L.P. (17)

91 transaction lines · from 17 filings · filed 2014-02-04 to 2018-06-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-06-25 S, Open-market sale Avadel Pharmaceuticals PLCAVDL 683,315, disposed Open Form 4 filing 0001193805-18-000909
2015-12-08 P, Open-market purchase Alimera Sciences IncALIM 2 lines 167,545, acquired Open Form 4 filing 0001193805-15-002006
2015-12-07 P, Open-market purchase Alimera Sciences IncALIM 2 lines 409,696, acquired Open Form 4 filing 0001193805-15-002006
2015-12-04 P, Open-market purchase Alimera Sciences IncALIM 2 lines 242,338, acquired Open Form 4 filing 0001193805-15-002006
2015-12-03 P, Open-market purchase Alimera Sciences IncALIM 2 lines 321,176, acquired Open Form 4 filing 0001193805-15-001989
2015-12-02 P, Open-market purchase Alimera Sciences IncALIM 2 lines 329,752, acquired Open Form 4 filing 0001193805-15-001989
2015-12-01 P, Open-market purchase Alimera Sciences IncALIM 2 lines 78,550, acquired Open Form 4 filing 0001193805-15-001989
2015-11-06 P, Open-market purchase Alimera Sciences IncALIM 2 lines 218,483, acquired Open Form 4 filing 0001193805-15-001839
2015-10-30 P, Open-market purchase Alimera Sciences IncALIM 2 lines 49,626, acquired Open Form 4 filing 0001193805-15-001808
2015-10-28 P, Open-market purchase Alimera Sciences IncALIM 2 lines 78,727, acquired Open Form 4 filing 0001193805-15-001798
2015-10-27 P, Open-market purchase Alimera Sciences IncALIM 2 lines 99,036, acquired Open Form 4 filing 0001193805-15-001798
2015-10-26 P, Open-market purchase Alimera Sciences IncALIM 2 lines 102,720, acquired Open Form 4 filing 0001193805-15-001765
2015-10-23 P, Open-market purchase Alimera Sciences IncALIM 2 lines 72,543, acquired Open Form 4 filing 0001193805-15-001765
2015-10-22 P, Open-market purchase Alimera Sciences IncALIM 2 lines 5,850, acquired Open Form 4 filing 0001193805-15-001765
2015-10-21 P, Open-market purchase Alimera Sciences IncALIM 2 lines 482,084, acquired Open Form 4 filing 0001193805-15-001758
2015-10-20 P, Open-market purchase Alimera Sciences IncALIM 2 lines 300,120, acquired Open Form 4 filing 0001193805-15-001758
2015-10-19 P, Open-market purchase Alimera Sciences IncALIM 2 lines 377,650, acquired Open Form 4 filing 0001193805-15-001758
2015-10-09 P, Open-market purchase Alimera Sciences IncALIM 2 lines 361,420, acquired Open Form 4 filing 0001193805-15-001704
2015-10-08 P, Open-market purchase Alimera Sciences IncALIM 2 lines 99,083, acquired Open Form 4 filing 0001193805-15-001704
2015-10-07 P, Open-market purchase Alimera Sciences IncALIM 2 lines 319,448, acquired Open Form 4 filing 0001193805-15-001704
2015-06-23 P, Open-market purchase Nivalis Therapeutics, Inc.NVLS 3 lines 3,500,000, acquired Open Form 4 filing 0001193805-15-001046
2015-01-28 P, Open-market purchase Auspex Pharmaceuticals, Inc.ASPX 5 lines 84,750,000, acquired Open Form 4 filing 0001193805-15-000056
2014-11-25 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 3 lines 1,402,598, disposed Open Form 4 filing 0001193805-14-002286

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Deerfield Private Design Fund II, L.P., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001483687

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.